The following table includes registration statements and
post-effective amendments that were declared effective by the
Securities and Exchange Commission on the most recently completed
business day.
The Securities Act of 1933 requires companies offering
securities to file a registration statement with the SEC that
discloses material facts for investors. The SEC staff reviews
registration statements and declares them "effective" if companies
satisfy the disclosure rules.
REGISTRATIONS EFFECTIVE AS OF July 10, 2012
STOCK:
ACCENTIA BIOPHARMACEUTICALS, INC. (ABPI)
File Number: 333-182376
Date of Original Registration: 6/27/2012
Form Type: S-1
Securities Registered: 1,607,148 Shares Of Common Stock
Selling Holder: Yes
FREESEAS INC. (FREE)
File Number: 333-182471
Date of Original Registration: 6/29/2012
Form Type: F-1
Securities Registered: 1,839,721 Shares of Common Stock
Selling Holder: Yes
MIXED SECURITIES:
BROOKFIELD ASSET MANAGEMENT INC (BAM)
File Number: 333-182092
Date of Original Registration: 6/13/2012
Form Type: F-10
"Securities Registered: $1,000,000,000 in Debt Securities ,
Class A Preference Shares, Class A Limited Voting Shares
Selling Holder: Yes
Synergy Pharmaceuticals Inc. (SGYP)
File Number: 333-182271
Date of Original Registration: 6/21/2012
Form Type: S-3
Securities Registered: $250,000,000 in Common Stock,
Preferred Stock, Warrants and Units.
Selling Holder: No
Order free Annual Report for Accentia BioPharmaceuticals,
Inc.
Visit http://djnewswires.ar.wilink.com/?link=ABPI or call
1-888-301-0513
Order free Annual Report for Brookfield Asset Management,
Inc.
Visit http://djnewswires.ar.wilink.com/?link=BAM or call
1-888-301-0513
Order free Annual Report for Synergy Pharmaceuticals, Inc.
Visit http://djnewswires.ar.wilink.com/?link=SGYP or call
1-888-301-0513